ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

CNTA Centessa Pharmaceuticals PLC

9.52
-0.41 (-4.13%)
17 Jul 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Centessa Pharmaceuticals PLC NASDAQ:CNTA NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  -0.41 -4.13% 9.52 9.12 9.95 9.69 9.17 9.69 302,057 23:56:46

FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Centessa Pharmaceuticals plc - CNTA

17/11/2022 3:50am

PR Newswire (US)


Centessa Pharmaceuticals (NASDAQ:CNTA)
Historical Stock Chart


From Jul 2022 to Jul 2024

Click Here for more Centessa Pharmaceuticals Charts.

CEDARHURST, N.Y., Nov. 16, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Centessa Pharmaceuticals plc (NasdaqGS: CNTA), if they purchased or otherwise acquired the Company's securities between May 28, 2021 and June 1, 2022, inclusive (the "Class Period") and/or purchased or otherwise acquired the Company's American Depositary Shares ("ADSs") pursuant to the Company's May 2021 initial public offering (the "IPO"). Shareholders have until November 28, 2022 to file lead plaintiff applications in the securities class action lawsuit.

KZ Law (PRNewsfoto/Kuznicki Law PLLC)

Shareholders are encouraged to contact us at https://kclasslaw.com/cases/securities/nasdaqgs-cnta/, by calling toll-free at 1-833-835-1495 or by email (dk@kclasslaw.com).

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: dk@kclasslaw.com
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967
https://kclasslaw.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/filing-deadline--kuznicki-law-pllc-announces-class-action-on-behalf-of-shareholders-of-centessa-pharmaceuticals-plc---cnta-301680809.html

SOURCE Kuznicki Law PLLC

Copyright 2022 PR Newswire

1 Year Centessa Pharmaceuticals Chart

1 Year Centessa Pharmaceuticals Chart

1 Month Centessa Pharmaceuticals Chart

1 Month Centessa Pharmaceuticals Chart

Your Recent History

Delayed Upgrade Clock